MESENCHIMAL STEM CELLS IN INFLAMMATORY BOWEL DISEASES: CLINICAL EVIDENCES AND POTENTIAL INSIGHTS FOR THE CLINICIANS

Mesenchimal stem cells (MSCs) have been used experimentally and clinically in the treatment of a wide variety of pathologies MSCs can be safely transplanted in autologous and allogenic ways as they are non-immunogenic, and consequently represent a therapeutic option for refractory connective tissue diseases, fibrosing diseases like scleroderma and fistulizing colitis like in Crohn's disease (CD). The immunomodulatory properties of MSCs have already shown promise when used as therapy for otherwise medically refractory CD. Accumulating evidence suggests that the properties may also be exploited of several other conditions. The currently available experimental and clinical data indicate that, …

Precursori di ADHD nei bambini moderatamente pretermine

Indagine su due popolazioni di rana verde (Pelophylax synklepton hispanicus) della Sicilia occidentale

Is splenectomy a treatment option for aseptic abscesses in patients with Crohn's disease?

IL P.I.A. (Prove Di Intelligenza Applicate) per la Valorizzazione Delle Differenze Individuali

Raccontando Aladino…Vincoli e possibilità del lavoro psico-socio-educativo in pediatria